nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—MAP2—age related macular degeneration	0.867	1	CbGaD
Docetaxel—Paclitaxel—MAP2—age related macular degeneration	0.00632	1	CrCbGaD
Docetaxel—MAPT—retina—age related macular degeneration	0.00217	0.0868	CbGeAlD
Docetaxel—MAP4—eye—age related macular degeneration	0.00172	0.0689	CbGeAlD
Docetaxel—MAP4—retina—age related macular degeneration	0.0017	0.0682	CbGeAlD
Docetaxel—MAP4—connective tissue—age related macular degeneration	0.00166	0.0663	CbGeAlD
Docetaxel—TUBB3—connective tissue—age related macular degeneration	0.00166	0.0663	CbGeAlD
Docetaxel—BCL2—connective tissue—age related macular degeneration	0.0015	0.0603	CbGeAlD
Docetaxel—MAP2—eye—age related macular degeneration	0.00135	0.0542	CbGeAlD
Docetaxel—MAP2—retina—age related macular degeneration	0.00134	0.0537	CbGeAlD
Docetaxel—TUBB4A—eye—age related macular degeneration	0.00105	0.0419	CbGeAlD
Docetaxel—TUBB4A—retina—age related macular degeneration	0.00104	0.0415	CbGeAlD
Docetaxel—TUBB2B—eye—age related macular degeneration	0.00101	0.0405	CbGeAlD
Docetaxel—TUBB4A—connective tissue—age related macular degeneration	0.00101	0.0404	CbGeAlD
Docetaxel—TUBB2B—retina—age related macular degeneration	0.001	0.0401	CbGeAlD
Docetaxel—TUBB2B—connective tissue—age related macular degeneration	0.000974	0.039	CbGeAlD
Docetaxel—TUBB2A—eye—age related macular degeneration	0.000951	0.0381	CbGeAlD
Docetaxel—TUBB2A—connective tissue—age related macular degeneration	0.000916	0.0367	CbGeAlD
Docetaxel—TUBB4B—eye—age related macular degeneration	0.000815	0.0327	CbGeAlD
Docetaxel—TUBB4B—retina—age related macular degeneration	0.000808	0.0324	CbGeAlD
Docetaxel—TUBB4B—connective tissue—age related macular degeneration	0.000786	0.0315	CbGeAlD
Docetaxel—CYP1B1—eye—age related macular degeneration	0.000646	0.0259	CbGeAlD
Docetaxel—CYP1B1—connective tissue—age related macular degeneration	0.000622	0.0249	CbGeAlD
Docetaxel—ABCB1—retina—age related macular degeneration	0.000235	0.00942	CbGeAlD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000187	0.00183	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.000185	0.00181	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD36—age related macular degeneration	0.000183	0.00179	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CFI—age related macular degeneration	0.000181	0.00177	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00018	0.00176	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—RHO—age related macular degeneration	0.000179	0.00175	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000178	0.00174	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.000176	0.00172	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—C3—age related macular degeneration	0.000174	0.0017	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000174	0.0017	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000174	0.0017	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000169	0.00166	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CFHR3—age related macular degeneration	0.000168	0.00164	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—ERCC6—age related macular degeneration	0.000166	0.00163	CbGpPWpGaD
Docetaxel—KIF11—Immune System—SQSTM1—age related macular degeneration	0.000166	0.00162	CbGpPWpGaD
Docetaxel—ABCC10—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000165	0.00161	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000161	0.00157	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—KDR—age related macular degeneration	0.00016	0.00157	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000159	0.00155	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000159	0.00155	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.000158	0.00154	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000151	0.00148	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000151	0.00148	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—C2—age related macular degeneration	0.00015	0.00147	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—CCL2—age related macular degeneration	0.00015	0.00146	CbGpPWpGaD
Docetaxel—EGFR—Bladder Cancer—VEGFA—age related macular degeneration	0.000146	0.00142	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.000144	0.00141	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000143	0.0014	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000143	0.0014	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.000142	0.00139	CbGpPWpGaD
Docetaxel—ABCC2—NRF2 pathway—SQSTM1—age related macular degeneration	0.000142	0.00139	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000132	0.00129	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.000131	0.00128	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.00013	0.00127	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000128	0.00125	CbGpPWpGaD
Docetaxel—ABCG2—HIF-2-alpha transcription factor network—VEGFA—age related macular degeneration	0.000126	0.00124	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CFH—age related macular degeneration	0.000125	0.00123	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—C9—age related macular degeneration	0.000123	0.00121	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CFB—age related macular degeneration	0.000122	0.00119	CbGpPWpGaD
Docetaxel—BCL2—Immune System—C9—age related macular degeneration	0.000121	0.00119	CbGpPWpGaD
Docetaxel—EGFR—Signaling events mediated by TCPTP—VEGFA—age related macular degeneration	0.000119	0.00116	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.000118	0.00115	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000115	0.00113	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000114	0.00111	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD36—age related macular degeneration	0.000111	0.00109	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000109	0.00107	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—C3—age related macular degeneration	0.000108	0.00106	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CFI—age related macular degeneration	0.000107	0.00105	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000106	0.00104	CbGpPWpGaD
Docetaxel—KIF11—Immune System—C3—age related macular degeneration	0.000105	0.00103	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CFI—age related macular degeneration	0.000105	0.00103	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—KDR—age related macular degeneration	0.000105	0.00103	CbGpPWpGaD
Docetaxel—TUBB6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000104	0.00102	CbGpPWpGaD
Docetaxel—TUBB2B—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000104	0.00102	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000103	0.001	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000103	0.001	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000101	0.000991	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000101	0.000991	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—VEGFA—age related macular degeneration	0.000101	0.000988	CbGpPWpGaD
Docetaxel—TUBB3—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000101	0.000986	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TGFBR1—age related macular degeneration	0.000101	0.000984	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CRP—age related macular degeneration	0.0001	0.000981	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0001	0.000979	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CFHR3—age related macular degeneration	9.94e-05	0.000972	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—C3—age related macular degeneration	9.81e-05	0.000959	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CFHR3—age related macular degeneration	9.79e-05	0.000957	CbGpPWpGaD
Docetaxel—TUBB2A—Transmembrane transport of small molecules—CETP—age related macular degeneration	9.76e-05	0.000955	CbGpPWpGaD
Docetaxel—KIF11—Immune System—TLR4—age related macular degeneration	9.61e-05	0.00094	CbGpPWpGaD
Docetaxel—TUBB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	9.55e-05	0.000933	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—NMNAT1—age related macular degeneration	9.53e-05	0.000932	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	9.36e-05	0.000915	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—SQSTM1—age related macular degeneration	9.12e-05	0.000892	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TLR4—age related macular degeneration	9.08e-05	0.000887	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	8.92e-05	0.000872	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	8.92e-05	0.000872	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—C2—age related macular degeneration	8.86e-05	0.000866	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—VEGFA—age related macular degeneration	8.83e-05	0.000863	CbGpPWpGaD
Docetaxel—BCL2—Immune System—C2—age related macular degeneration	8.73e-05	0.000853	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—CETP—age related macular degeneration	8.57e-05	0.000838	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ELOVL4—age related macular degeneration	8.33e-05	0.000815	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RDH8—age related macular degeneration	8.05e-05	0.000787	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NMNAT1—age related macular degeneration	8.05e-05	0.000787	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—CETP—age related macular degeneration	7.84e-05	0.000767	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—CCL2—age related macular degeneration	7.79e-05	0.000761	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	7.72e-05	0.000755	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—SQSTM1—age related macular degeneration	7.71e-05	0.000754	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—CCL2—age related macular degeneration	7.68e-05	0.000751	CbGpPWpGaD
Docetaxel—EGFR—Disease—NMNAT1—age related macular degeneration	7.58e-05	0.000742	CbGpPWpGaD
Docetaxel—EGFR—Disease—RDH8—age related macular degeneration	7.58e-05	0.000742	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—CETP—age related macular degeneration	7.46e-05	0.000729	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	7.45e-05	0.000728	CbGpPWpGaD
Docetaxel—ABCG2—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	7.43e-05	0.000727	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CFH—age related macular degeneration	7.41e-05	0.000725	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CFH—age related macular degeneration	7.3e-05	0.000714	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CFB—age related macular degeneration	7.18e-05	0.000703	CbGpPWpGaD
Docetaxel—EGFR—Immune System—C9—age related macular degeneration	7.18e-05	0.000702	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—CETP—age related macular degeneration	7.08e-05	0.000693	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CFB—age related macular degeneration	7.08e-05	0.000692	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RPE65—age related macular degeneration	7.03e-05	0.000688	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	6.94e-05	0.000679	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—C3—age related macular degeneration	6.92e-05	0.000677	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—NMNAT1—age related macular degeneration	6.74e-05	0.000659	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—SLC16A8—age related macular degeneration	6.72e-05	0.000657	CbGpPWpGaD
Docetaxel—EGFR—Disease—RPE65—age related macular degeneration	6.63e-05	0.000648	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	6.61e-05	0.000646	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NMNAT1—age related macular degeneration	6.52e-05	0.000637	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CFI—age related macular degeneration	6.23e-05	0.000609	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—KDR—age related macular degeneration	6.2e-05	0.000606	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	5.93e-05	0.00058	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NMNAT1—age related macular degeneration	5.93e-05	0.00058	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ELOVL4—age related macular degeneration	5.89e-05	0.000576	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NMNAT1—age related macular degeneration	5.88e-05	0.000575	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—C3—age related macular degeneration	5.79e-05	0.000567	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CFHR3—age related macular degeneration	5.79e-05	0.000566	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—VEGFA—age related macular degeneration	5.78e-05	0.000565	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	5.75e-05	0.000563	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ELOVL4—age related macular degeneration	5.7e-05	0.000557	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ABCA4—age related macular degeneration	5.67e-05	0.000554	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—RHO—age related macular degeneration	5.51e-05	0.000539	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	5.46e-05	0.000534	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	5.41e-05	0.000529	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—APOE—age related macular degeneration	5.39e-05	0.000528	CbGpPWpGaD
Docetaxel—EGFR—Disease—ABCA4—age related macular degeneration	5.34e-05	0.000523	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RDH8—age related macular degeneration	5.31e-05	0.000519	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—KDR—age related macular degeneration	5.29e-05	0.000517	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	5.28e-05	0.000516	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	5.27e-05	0.000515	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ELOVL4—age related macular degeneration	5.18e-05	0.000507	CbGpPWpGaD
Docetaxel—EGFR—Immune System—C2—age related macular degeneration	5.16e-05	0.000504	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ELOVL4—age related macular degeneration	5.14e-05	0.000502	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	5.09e-05	0.000498	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—CETP—age related macular degeneration	5.07e-05	0.000495	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—CETP—age related macular degeneration	5.01e-05	0.00049	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD36—age related macular degeneration	4.99e-05	0.000488	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RHO—age related macular degeneration	4.93e-05	0.000482	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	4.82e-05	0.000472	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	4.82e-05	0.000472	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—SLC16A8—age related macular degeneration	4.75e-05	0.000464	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—C3—age related macular degeneration	4.73e-05	0.000462	CbGpPWpGaD
Docetaxel—EGFR—Disease—RHO—age related macular degeneration	4.65e-05	0.000455	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RPE65—age related macular degeneration	4.64e-05	0.000454	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—SLC16A8—age related macular degeneration	4.59e-05	0.000449	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCL2—age related macular degeneration	4.53e-05	0.000443	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CRP—age related macular degeneration	4.5e-05	0.00044	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	4.48e-05	0.000438	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—CETP—age related macular degeneration	4.41e-05	0.000431	CbGpPWpGaD
Docetaxel—BCL2—Immune System—SQSTM1—age related macular degeneration	4.33e-05	0.000424	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CFH—age related macular degeneration	4.32e-05	0.000422	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—TLR4—age related macular degeneration	4.31e-05	0.000422	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NMNAT1—age related macular degeneration	4.25e-05	0.000415	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—CCL2—age related macular degeneration	4.23e-05	0.000413	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—CCL2—age related macular degeneration	4.23e-05	0.000413	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CFB—age related macular degeneration	4.18e-05	0.000409	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SLC16A8—age related macular degeneration	4.18e-05	0.000409	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SLC16A8—age related macular degeneration	4.14e-05	0.000405	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	4.1e-05	0.000401	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—CCL2—age related macular degeneration	4.08e-05	0.000399	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—KDR—age related macular degeneration	4.05e-05	0.000396	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	4.02e-05	0.000393	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—CCL2—age related macular degeneration	3.95e-05	0.000387	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	3.95e-05	0.000386	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—CCL2—age related macular degeneration	3.87e-05	0.000378	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ABCA4—age related macular degeneration	3.74e-05	0.000366	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	3.71e-05	0.000363	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	3.48e-05	0.00034	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CCL2—age related macular degeneration	3.47e-05	0.000339	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—LIPC—age related macular degeneration	3.44e-05	0.000336	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—VEGFA—age related macular degeneration	3.42e-05	0.000334	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	3.4e-05	0.000333	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CD36—age related macular degeneration	3.34e-05	0.000327	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CETP—age related macular degeneration	3.32e-05	0.000324	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RHO—age related macular degeneration	3.26e-05	0.000318	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NMNAT1—age related macular degeneration	3.21e-05	0.000314	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CCL2—age related macular degeneration	3.17e-05	0.00031	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	3.16e-05	0.000309	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CST3—age related macular degeneration	3.08e-05	0.000302	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	3.06e-05	0.000299	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	2.99e-05	0.000293	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD36—age related macular degeneration	2.95e-05	0.000288	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—VEGFA—age related macular degeneration	2.91e-05	0.000285	CbGpPWpGaD
Docetaxel—EGFR—Disease—CST3—age related macular degeneration	2.91e-05	0.000284	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD36—age related macular degeneration	2.91e-05	0.000284	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KDR—age related macular degeneration	2.89e-05	0.000282	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD36—age related macular degeneration	2.83e-05	0.000277	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ELOVL4—age related macular degeneration	2.8e-05	0.000274	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—C3—age related macular degeneration	2.8e-05	0.000273	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	2.79e-05	0.000273	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFBR1—age related macular degeneration	2.77e-05	0.000271	CbGpPWpGaD
Docetaxel—BCL2—Immune System—C3—age related macular degeneration	2.75e-05	0.000269	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	2.7e-05	0.000264	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—C3—age related macular degeneration	2.68e-05	0.000262	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CRP—age related macular degeneration	2.66e-05	0.00026	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CRP—age related macular degeneration	2.62e-05	0.000256	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFBR1—age related macular degeneration	2.61e-05	0.000255	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SQSTM1—age related macular degeneration	2.56e-05	0.000251	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TLR4—age related macular degeneration	2.55e-05	0.000249	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TLR4—age related macular degeneration	2.51e-05	0.000246	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—LIPC—age related macular degeneration	2.43e-05	0.000238	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	2.38e-05	0.000233	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—LIPC—age related macular degeneration	2.35e-05	0.00023	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CETP—age related macular degeneration	2.35e-05	0.000229	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CETP—age related macular degeneration	2.27e-05	0.000222	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC16A8—age related macular degeneration	2.26e-05	0.000221	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—VEGFA—age related macular degeneration	2.23e-05	0.000218	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—LIPC—age related macular degeneration	2.14e-05	0.000209	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—LIPC—age related macular degeneration	2.12e-05	0.000207	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CETP—age related macular degeneration	2.06e-05	0.000202	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CETP—age related macular degeneration	2.05e-05	0.0002	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CD36—age related macular degeneration	1.99e-05	0.000195	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	1.98e-05	0.000193	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFBR1—age related macular degeneration	1.83e-05	0.000179	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—C3—age related macular degeneration	1.78e-05	0.000174	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—APOE—age related macular degeneration	1.76e-05	0.000172	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	1.73e-05	0.000169	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD36—age related macular degeneration	1.72e-05	0.000168	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	1.72e-05	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SQSTM1—age related macular degeneration	1.66e-05	0.000162	CbGpPWpGaD
Docetaxel—EGFR—Immune System—C3—age related macular degeneration	1.63e-05	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—age related macular degeneration	1.59e-05	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CRP—age related macular degeneration	1.55e-05	0.000151	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—LIPC—age related macular degeneration	1.53e-05	0.00015	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR4—age related macular degeneration	1.48e-05	0.000145	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APOE—age related macular degeneration	1.48e-05	0.000145	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CETP—age related macular degeneration	1.48e-05	0.000145	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CD36—age related macular degeneration	1.41e-05	0.000138	CbGpPWpGaD
Docetaxel—EGFR—Disease—APOE—age related macular degeneration	1.4e-05	0.000137	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL2—age related macular degeneration	1.39e-05	0.000136	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	1.39e-05	0.000136	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CD36—age related macular degeneration	1.36e-05	0.000133	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—APOE—age related macular degeneration	1.24e-05	0.000122	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CD36—age related macular degeneration	1.24e-05	0.000121	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CD36—age related macular degeneration	1.23e-05	0.00012	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—APOE—age related macular degeneration	1.2e-05	0.000118	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—LIPC—age related macular degeneration	1.16e-05	0.000113	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CETP—age related macular degeneration	1.12e-05	0.000109	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—APOE—age related macular degeneration	1.09e-05	0.000107	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—APOE—age related macular degeneration	1.08e-05	0.000106	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—C3—age related macular degeneration	1.05e-05	0.000103	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOE—age related macular degeneration	9.8e-06	9.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KDR—age related macular degeneration	9.6e-06	9.39e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CD36—age related macular degeneration	8.89e-06	8.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL2—age related macular degeneration	8.24e-06	8.05e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOE—age related macular degeneration	7.84e-06	7.67e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LIPC—age related macular degeneration	7.12e-06	6.97e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CETP—age related macular degeneration	6.87e-06	6.72e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CD36—age related macular degeneration	6.71e-06	6.56e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOE—age related macular degeneration	5.92e-06	5.78e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—age related macular degeneration	5.29e-06	5.17e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CD36—age related macular degeneration	4.13e-06	4.04e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOE—age related macular degeneration	3.64e-06	3.56e-05	CbGpPWpGaD
